Earth Science Tech (ETST) AI Stock Analysis

• Market Cap: $51.50M
• Dividend Yield: N/A
• Average Volume (3M): 124.84K
• Price to Earnings (P/E): 16.4
• Beta (1Y): 1.59
• Revenue Growth: 177.05%
• EPS Growth: 311.54%
• Country: US
• Employees: 32
• Sector: Healthcare
• Sector Strength: 42
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): N/A
• Shares Outstanding: 294,297,600
• 10 Day Avg. Volume: 120,556
• 30 Day Avg. Volume: 124,843
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 68 Neutral
• Price Target: $0.00 ▼(-100.00%Downside)

Earth Science Tech demonstrates strong technical indicators and positive corporate events, supporting a bullish outlook. Despite past financial challenges, recent improvements suggest a more stable future.

Earth Science Tech Business Overview & Revenue Model

Company Description

Earth Science Tech, Inc., a biotechnology company, focuses on delivering nutraceuticals, bioceuticals, and dietary supplements in the areas of health, wellness, nutrition, supplement, cosmetic, and alternative medicine worldwide. The company focuses on delivering nutritional and dietary supplements for the treatment of chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging, and overall wellness. Its products include hemp oils, vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods, and other products. The company markets its products in a range of formulations and delivery forms, including capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs through its retail store, clinics, pharmacies, as well as through online. It also provides medical equipment and devices. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. The company was incorporated in 2010 and is headquartered in Doral, Florida.

How the Company Makes Money

Earth Science Tech generates revenue through the sale of its cannabinoid-based health and wellness products, including dietary supplements and medical devices. The company's revenue model is largely built upon direct sales to consumers and partnerships with distributors who help bring their products to a wider audience. ETST may also engage in licensing agreements, allowing other companies to produce and sell products based on its proprietary formulations and technologies. Additionally, the company could potentially earn revenue from collaborations with research institutions or pharmaceutical companies interested in commercializing its scientific innovations.

Earth Science Tech Financial Statement Overview

Summary

Earth Science Tech has shown strong revenue growth and improved cash flow, indicating a positive trend in financial recovery. However, past financial instability and high leverage remain concerns, affecting the stability of profitability.

Income Statement

Earth Science Tech has shown impressive revenue growth, with a significant increase from $140,902 in 2021 to $33,117,624 in 2025. The gross profit margin has also improved, indicating better cost management. However, the net profit margin has been volatile due to fluctuating net income, impacting overall profitability stability.

Balance Sheet

The company's debt-to-equity ratio has improved with a positive equity position as of 2025, contrasting with negative equity in earlier years. However, the relatively high total debt and liabilities still pose a financial stability risk. The return on equity has been erratic due to previous negative equity.

Cash Flow

Earth Science Tech's cash flow situation is strengthening, with significant growth in operating cash flow and positive free cash flow in recent years. The free cash flow to net income ratio suggests efficient cash generation from profits. However, earlier periods showed negative cash flows, indicating past challenges.

Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Earth Science Tech Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.21
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ETST, the sentiment is Positive. The current price of 0.21 is above the 20-day moving average (MA) of 0.19, above the 50-day MA of 0.17, and above the 200-day MA of 0.15, indicating a bullish trend. The MACD of 0.01 indicates Negative momentum. The RSI at 62.26 is Neutral, neither overbought nor oversold. The STOCH value of 90.48 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ETST.

Earth Science Tech Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ETST	68 Neutral	$51.50M	16.36	106.67%	―	177.05%	311.54%
Sector *	57 Neutral	£4.92B	7.01	-62.36%	19.23%	34.03%	6.31%
RMTI	57 Neutral	$35.20M	―	-2.12%	―	12.82%	96.46%
CPHI	43 Neutral	$5.97M	―	-59.14%	―	-33.10%	71.37%
KALA	31 Underperform	$52.20M	―	-576.46%	―	―	38.50%
SXTC	―	$184.48M	0.07	57.63%	―	―	―
IXHL	39 Underperform	$98.38M	―	-201.88%	―	―	―

Earth Science Tech Corporate Events

Earth Science Tech Joins OTCID Tier for Growth

On July 1, 2025, Earth Science Tech, Inc. announced its qualification for and listing on the newly launched OTCID tier of the OTC Markets, reflecting its commitment to enhanced disclosure, transparency, and compliance standards. This achievement is expected to boost investor confidence, attract new stakeholders, and support the company’s strategic growth initiatives, marking a significant turnaround for the company over the past two years.

Earth Science Tech Reports Strong Fiscal Year Results

Earth Science Tech, Inc. reported its financial results for the fiscal year ending March 31, 2025, showcasing significant growth with revenue exceeding $33.1 million and a net profit of $3.2 million. The company achieved a 177.05% increase in revenue and a 300.63% rise in net profit compared to the previous year. The results reflect a strong year-over-year improvement in cash, total assets, and gross profit, indicating robust operational performance and strategic growth. Additionally, the company reduced its outstanding shares by 4.72%, enhancing shareholder value.

Earth Science Tech Reports Record-Breaking Financial Results

Earth Science Tech, Inc. reported record-breaking projected financial results for the fiscal year ending March 31, 2025, with a projected net income of $3.6 million and revenue surpassing $32 million, marking significant year-over-year growth. The company expanded its board, qualified for a new market listing, increased its workforce, and made several strategic acquisitions, including Mister Meds and Las Villas Health Care, positioning itself for continued growth and innovation in the coming fiscal year.